Rigel Pharmaceuticals, Inc. has announced the approval of a new Inducement Plan by its Board's Compensation Committee, aimed at providing stock-based incentives to employees. As part of this plan, Rigel has granted 23,075 stock options and restricted stock units to 10 non-executive employees. These awards are set to vest over a four-year period, with an initial one-year cliff, in compliance with NASDAQ Listing Rule 5635(c)(4). This move is part of Rigel's efforts to recognize and reward its employees as they join the company.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。